Dublin, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The "2nd Annual Single Cell-Omics Conference" conference has been added to ResearchAndMarkets.com's offering.
Scrutinizing the Innovative Research in Single-Cell Omics
The conference will assimilate diverse sessions on a broad perspective of novel research and development in the field of multi-omics research. The event encompasses Researchers, Scientists from top universities and pharmaceutical companies from all around the globe and provides the platform to share knowledge with academic peers and present their research papers and reports.
The fundamentals of Single Cell have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. Recent advances in single-cell technologies have opened new opportunities to signify the intra-tumour cell heterogeneity, identify rare cell kinds, degrees of mutation, and ultimately guide diagnosis and treatment options.
Omics technologies helps in comprehensive examination of genome biology (Genomics), proteins (Proteomics) and RNA molecules (Transcriptomics) which in turn are used for drug discovery and development. Thus, these single cell omics prospects are much anticipated to revolutionise our adequacy to understand the magnitude of omics diversity occurring in our biological systems.
WHAT TO EXPECT
Key Highlights:
-
Single-cell genomic analysis for cancer/cellular heterogeneity
-
Single Cell Transcriptional Profiling, Digital spatial profiling
-
Spatial Single cell genome analysis - Sequencing application
-
Single-Cell phenotyping
-
Application of multiplex imaging - Single cell and tissue imaging
-
Current & Emerging Tools and Data Analysis in Single Cell Omics
-
Single Cell Analysis in Drug Discovery & Development - Sample Preparation and Processing
-
Microfluidics Tools for Single Cell Analysis
-
Cancer Biomarker discovery
-
Nanopore Technology - A Potential Application in Functional Genomics
Why Attend?
-
Witness live action how Single-Cell Omics technology is revolutionizing the future of Biomedical Research
-
Quality insights and cohesiveness of key issues with respect to Single-Cell to be addressed
-
Discover the different avenues in the application of Multi-Omics studies
-
Comprehend the current and future research avenues of Single-Cell Omics in drug discovery and development
-
Discuss the emerging technologies and opportunities with cutting-edge strategies
-
Opportunity for one-on-one networking with the delegates and extend professional competency
Who Should Attend:
-
Industry: Pharma/Therapeutic Companies/Start Up's
-
CEOs, CMO's, CSO's, COO's, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders
-
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science, Microbiologists, Virologists, Pathologists
-
Academics: Universities, Research Institutes, Hospitals
-
Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
-
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science, Microbiologists, Virologists, Pathologists